Association between the T27C polymorphism in the cytochrome P450 c17α (CYP17) gene and risk factors for breast cancer

Breast Cancer Research and Treatment

Volumn 88, Issue 3, 2004, Pages 217-230

  Hong, Chi Chen ^a   Thompson, Henry J ^b   Jiang, Cheng ^c   Hammond, Geoffrey L ^d   Tritchler, David ^a   Yaffe, Martin ^e   Boyd, Norman F ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^e Med Imaging Res Sunnybrook W   (Canada)

Author keywords

Cytochrome P450 c17 ; Diet; Insulin; Mammographic density; Sex hormones

Indexed keywords

CYTOCHROME P450 17; ESTRADIOL; FOLLITROPIN; GROWTH FACTOR; INSULIN; PRASTERONE SULFATE; SEX HORMONE;

ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CHEMICAL INTERACTION; CONTROLLED STUDY; DIET; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HORMONE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

ADULT; BREAST; BREAST NEOPLASMS; CROSS-SECTIONAL STUDIES; DIET; FEMALE; GONADAL STEROID HORMONES; GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MAMMOGRAPHY; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE;

EID: 12344312120     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-0780-7     Document Type: Article

References (74)

1. The Endogenous Hormones and Breast Cancer Collaborative Group: Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94: 606-616, 2002
2. Olsson H, Bladstrom A: A cohort study of reproductive factors and family history of breast cancer in southern Sweden. Breast Cancer Res Treat 76: 203-209, 2002
3. Lahmann PH, Lissner L, Gullberg B, Olsson H, Berglund G: A prospective study of adiposity and postmenopausal breast cancer risk: the Malmo Diet and Cancer Study. Int J Cancer 103: 246-252, 2003
4. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333, 2002
5. Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA: Association of diet and mammographic breast density in the Minnesota Breast Cancer Family Cohort. Cancer Epidemiol Biomarkers Prev 9: 151-160, 2000
6. Boyd NF, Lockwood GA, Byng J, Tritchler DL, Yaffe M: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7: 1133-1144, 1998
7. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA: Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control 11: 653-662, 2000
8. Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MRE, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL: Heritability of mammographic density, a risk factor for breast cancer. The New England J Med 347: 886-894, 2002
9. Greendale GA, Reboussin BA, Sie A, Singh R, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E: Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Annals of Internal Medicine 130(4): 262-269, 1999
10. Brisson J, Brisson B, Coté G, Maunsell E, Bérubé S, Robert J: Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 9: 911-915, 2000
11. Miller WL: Early steps in androgen biosynthesis: from cholesterol to DHEA. Baillieres Clin Endocrinol Metab 12: 67-81, 1998
12. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE: A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 57: 1063-1065, 1997
13. Feigelson HS, Shames LS, Pike MC, Coetzee GA, Stanczyk FZ, Henderson BE: cytochrome p450c17 and gene (cyp17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Research 58: 585-587, 1998
14. Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ: The relationship between a polymorphism in cyp17 with plasma hormone levels and breast cancer. Cancer Research 59: 1015-1020, 1999
15. Haiman CA, Bernstein L, Berg D, Ingles SA, Salane M, Ursin G: Genetic determinants of mammographic density. Breast Cancer Res 4: R5, 2002
16. Haiman CA, Hankinson SE, De VI, Guillemette C, Ishibe N, Hunter DJ, Byrne C: Polymorphisms in steroid hormone pathway genes and mammographic density. Breast Cancer Res Treat 77: 27-36, 2003
17. Boyd NF, Stone J, Martin LJ, Jong R, Fishell E, Yaffe M, Hammond G, Minkin S: The association of breast mitogens with mammographic densities. British J Cancer 87(8): 876-882, 2002
18. Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF: Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 12: 838-847, 2003
19. Block G, Thompson FE, Hartman AM, Larkin FA, Guire KE: Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 92: 686-693, 1992
20. Block G, Mandel R, Gold E: On food frequency questionnaires: the contribution of open-ended questions and questions on ethnic foods. Epidemiology 15: 216-221, 2004
21. Langley MS, Hammond GL, Bardsley A, Sellwood RA, Anderson DC: Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases. J Natl Cancer Inst 75: 823-829, 1985
22. National Heart LaBI: Manual of Laboratory Operations, Lipid Research Clinics Program - 1. Lipid and Lipoprotein Analysis. 2: 1982
23. Wang L, Hirayasu K, Ishizawa M, Kobayashi Y: Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated Na1 and SDS. Nucleic Acids Res 22: 1774-1775, 1994
24. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ: The quantitative analysis of mammographic densities. Phys Med Biol 39: 1629-1638, 1994
25. SAS Institute Inc: SAS/STAT User's Guide. Version 6.4: 1989
26. Katz MH: Multivariable Analysis: A Practical Guide for Clinicians, 1999
27. Helzlsouer KJ, Huang H-Y, Strickland PT, Hoffman S, Alberg AJ, Comstock GW, Bell DA: Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 7: 945-949, 1998
28. Summers LK, Fielding BA, Bradshaw HA, Ilic V, Beysen C, Clark ML, Moore NR, Frayn KN: Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 45: 369-377, 2002
29. Paeratakul S, Popkin BM, Keyou G, Adair LS, Stevens J: Changes in diet and physical activity affect the body mass index of Chinese adults. Int J Obes Relat Metab Disord 22: 424-431, 1998
30. Sherwood NE, Jeffery RW, French SA, Hannan PJ, Murray DM: Predictors of weight gain in the Pound of Prevention study. Int J Obes Relat Metab Disord 24: 395-403, 2000
31. Ye Z, Parry JM: The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 17: 119-126, 2002
32. Kaaks R, Lukanova A: Effects of weight control and physical activity in cancer prevention: role of endogenous hormone metabolism. Ann N Y Acad Sci 963: 268-281, 2002
33. Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD: Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 20: 151-156, 1991
34. Teramukai S, Rohan T, Eguchi H, Oda T, Shinchi K, Kono S: Anthropometric and behavioral correlates of insulin-like growth factor I and insulin-like growth factor binding protein 3 in middle-aged Japanese men. Am J Epidemiol 156: 344-348, 2002
35. Lukanova A, Soderberg S, Stattin P, Palmqvist R, Lundin E, Biessy C, Rinaldi S, Riboli E, Hallmans G, Kaaks R: Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control 13: 509-516, 2002
36. Yamamoto H, Kato Y: Relationship between plasma insulin-like growth factor I (IGF-I) levels and body mass index (BMI) in adults. Endocr J 40: 41-45, 1993
37. Magoffin DA, Weitsman SR: Differentiation of ovarian theca-interstitial cells in vitro: regulation of 17 alpha-hydroxylase messenger ribonucleic acid expression by luteinizing hormone and insulin-like growth factor-I. Endocrinology 132: 1945-1951, 1993
38. Kristiansen SB, Endoh A, Casson PR, Buster JE, Hornsby PJ: Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells. Steroids 62: 258-265, 1997
39. Nestler JE, Jakubowicz DJ: Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335: 617-623, 1996
40. Miller WL, Auchus RJ, Geller DH: The regulation of 17,20 lyase activity. Steroids 62: 133-142, 1997
41. Plymate SR, Matej LA, Jones RE, Friedl KE: Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 67: 460-464, 1988
42. Clauson PG, Brismar K, Hall K, Linnarsson R, Grill V: Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. Scand J Clin Lab Invest 58: 353-360, 1998
43. Casson PR, Faquin LC, Stentz FB, Straughn AB, Andersen RN, Abraham GE, Buster JE: Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril 63: 1027-1031, 1995
44. Janssen YJ, Helmerhorst F, Frolich M, Roelfsema F: A switch from oral (2 mg/day) to transdermal (50 microg/ day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J Clin Endocrinol Metab 85: 464-467, 2000
45. Cano A, Castelo-branco C, Tarin JJ: Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels. Fertil Steril 71(2): 261-267, 1999
46. Key TJ: Serum oestradiol and breast cancer risk. Endocr Relat Cancer 6: 175-180, 1999
47. Gram IT, Ursin G, Spicer DV, Pike MC: Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment. Cancer Epidemiol Biomarkers Prev 10: 1117-1120, 2001
48. Hankinson SE, Willet WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351: 1393-1396, 1998
49. Byrne C, Colditz GA, Willet WC, Speizer FE, Pollak M, Hankinson SE: Plasma insulin-like growth factor (IGF) I, IGF-binding Protein 3, and mammographic density. Cancer Research 60: 3744-3748, 2000
50. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwill PJ: Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-120, 1998
51. Bruning PF, Bonfrèr JMG, van Noord PAH, Hart AAM, de Jong-Bakker M, Nooijen WJ: Insulin resistance and breast-cancer risk. Int J Cancer 52: 511-516, 1992
52. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A: Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 9: 1343-1348, 2000
53. Goodman MT, McDuffie K, Guo C, Terada K, Donlon TA: CYP17 genotype and ovarian cancer: a null case-control study. Cancer Epidemiol Biomarkers Prev 10: 563-564, 2001
54. Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S, Graham S, Vena JE, Shields PG: CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors. Breast Cancer Res 5: R45-R51, 2003
55. Feigelson HS, McKean-Cowdin R, Pike MC, Coetzee GA, Kolonel LN, Nomura AMY, Marchand LL, Henderson BE: Cytochrome p450c17 and gene (cyp17) polymorphism predicts use of hormone replacement therapy. Cancer Research 59: 3908-3910, 1999
56. Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I: A polymorphism in cyp17 and endometrial cancer risk. Cancer Research 61: 3955-3960, 2001
57. Garcia-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF: Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer 102: 172-178, 2002
58. Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ, McTiernan A: Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13: 94-101, 2004
59. Muti P, Trevisan M, Micheli A, Krogh V, Bolelli G, Sciajno R, Berrino F: Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 5: 917-922, 1996
60. Michaud DS, Manson JE, Spiegelman D, Barbieri RL, Sepkovic D, Bradlow HL, Hankinson SE: Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 8: 1059-1064, 1999
61. Genazzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR: Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women. Fertil Steril 76: 241-248, 2001
62. Goodman-Gruen D, Barrett-Connor E: Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol 145: 970-976, 1997
63. Weston A, Pan C-F, Bleiweiss IJ, Ksieski HB, Roy N, Maloney N, Wolff MS: CYP17 genotype and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7: 941-944, 1998
64. Wu AH, Seow A, Arakawa K, Van Den BD, Lee HP, Yu MC: HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore. Int J Cancer 104: 450-457, 2003
65. Goodwill PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N: Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20: 42-51, 2002
66. Tymchuk CN, Tessler SB, Aronson WJ, Barnard RJ: Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen. Nutr Cancer 31: 127-131, 1998
67. Nestler JE, Jakubowicz DJ: Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 82: 4075-4079, 1997
68. Ivandic A, Prpic-Krizevac I, Sucic M, Juric M: Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity. Metabolism 47: 13-19, 1998
69. Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm A, Graham S, Holmberg L, Howe G, Marshall JR, Miller AB, Potter JD, Speizer FE, Willett WC, Wolk A, Hunter DJ: Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA 279: 535-540, 1998
70. Knight JA, Martin LJ, Greenberg CV, Lockwood GA, Byng JW, Yaffe MJ, Tritchler DL, Boyd NF: Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiol Biomarkers Prev 8: 123-128, 1999
71. Brisson J, Verreault R, Morrison A, Tennina S, Meyer F: Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 130: 14-24, 1989
72. Velie E, Kulldorff M, Schairer C, Block G, Albanes D, Schatzkin A: Dietary fat, fat subtypes, and breast cancer in postmenopausal women: a prospective cohort study. J Natl Cancer Inst 92: 833-839, 2000
73. Reichman ME, Judd JT, Longcope C, Schatzkin A, Clevidence BA, Nair PP, Campbell WS, Taylor PR: Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. J Natl Cancer Inst 85: 722-727, 1993
74. Holmes MD, Spiegelman D, Willett WC, Manson JE, Hunter DJ, Barbieri RL, Colditz GA, Hankinson SE: Dietary fat intake and endogenous sex steroid hormone levels in postmenopausal women. J Clin Oncol 18: 3668-3676, 2000